Ravulizumab

Therapeutic Ravulizumab antibody from the original Ultomiris® commercial drug
Amount per aliquot: 10 mg

Product Specifications:​​

  • Quality Standard clinical-grade
  • Product Concentration 10 mg/mL
  • Volume per Aliquot 1000 µL
  • Quantity per Aliquot 10 mg
  • Origin of the Commercial Drug DE
  • Batch Number
  • Storage Temperature
  • Original Therapeutic Expiry Date

Our products are for research use only. The “therapeutic expiration date” refers to the expiry date for patient adminstration and is not applicable to the shelf life of the aliquot. Aliquot storage at -70°C ensures fully functional molecules even after the mentioned expiry date.

Product Information:

“Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots, aRMP, or aliquots.

We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at the recommended temperature -70°C, ensuring fully functional molecules for research purposes.”

As ‘raw material’ for the production of drug aliquots, Evidentic sources RMP from the European (EU) market. As a licensed pharmaceutical wholesaler, Evidentic is committed to Good Distribution Practice (GDP) compliance with respect to the procurement, storage and shipment of RMP.

Drug aliquots are manufactured by repackaging RMP in a qualified laboratory. The aliquotation process is performed under a quality and manufacturing agreement between Evidentic and the contract manufacturer. Repackaging of RMP includes the following steps: opening the secondary and primary RMP containers and transferring the specified volumes of RMP into an Eppendorf 0.5 ml low-binding (or similar) tube. If the RMP is a lyophilized powder and not a highly concentrated solution, reconstitute the RMP according to the original manufacturer’s instructions and then aliquot as a highly concentrated solution.

For identification purposes, drug aliquots are labeled with the date of aliquoting, the original lot number of the RMP, the original expiration date of the RMP, the name of the active ingredient (INN), and a unique identification code.

Immediately after aliquoting, drug aliquots are stored at either 2-8 °C or -86 °C for long-term storage. All drug aliquots stored at 2-8 °C are transferred to -86 °C at least two weeks before the expiration date of the original RLD/RMP is reached.

Further quality or functional testing are not performed on the drug aliquots.

Class of Molecule

Host cells

Chinese hamster ovary (CHO) cell

Prepared from (Reference drug)​

Ultomiris®

Therapeutic Area

Mechanism of Action (MoA)

Ravulizumab is a monoclonal antibody IgG2/4K that specifically binds to the complement protein C5, thereby inhibiting its cleavage to C5a (the proinflammatory anaphylatoxin) and C5b (the initiating subunit of the membrane attack complex [MAC or C5b-9]) and preventing the generation of the C5b-9. Ravulizumab preserves the early components of complement activation that are essential for opsonisation of microorganisms and clearance of immune complexes.

Pharmacotherapeutic group​​

Immunosuppressants, selective immunosuppressants

List of Excipients​

Sodium phosphate dibasic heptahydrate
Sodium phosphate monobasic monohydrate
Polysorbate 80
Arginine
Sucrose
Water for injections

Ready to simplify your sourcing?

Here’s how to get started:

Select Your Licensed Molecules

Browse our shop and choose the licensed molecules you need. Don’t worry if you can’t find the molecule you’re looking for – we can source it for you!

Get a Quote

Receive a confidential, non-binding quote for the molecule(s) you choose.

Get Qualified & We Deliver

Complete our quick qualification process, place your order, and we’ll ship your molecule(s) within days.

More Reference Drugs as Aliquots

Filters Sort results
Reset Apply
Product Batch
Expiry Date
Brand & Origin
Amount per Aliquot
Select Quantity
Discount
Price per Aliquot
2021.12
Amgevita®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
304,00  /aliquot
2026.02
Humira®
DE
4 mg
Max: 20
Min: 1
Step: 1
aliquot
338,00 /mg
2023.02
Hulio®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
304,00  /aliquot
2023.10
Hukyndra®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
354,00  /aliquot
2024.02
Yuflyma®
DE
4 mg
Max: 3
Min: 1
Step: 1
aliquot
Order on demand:
0%
354,00  /aliquot
2018.12
Humira®
LV
4 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
451,00  /aliquot
2019.03
Humira®
DE
4 mg
Max: 9
Min: 1
Step: 1
aliquot
Order on demand:
0%
451,00  /aliquot
2019.03
Humira®
DE
4 mg
Max: 5
Min: 1
Step: 1
aliquot
Order on demand:
0%
451,00  /aliquot
2019.07
Humira®
DE
4 mg
Max: 6
Min: 1
Step: 1
aliquot
Order on demand:
0%
451,00  /aliquot
2023.10
Idacio®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
355,00  /aliquot
2023.10
Imraldi®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
304,00  /aliquot
2024.06
Hyrimoz®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
304,00  /aliquot